Recent studies showed that these PARP inhibitors induced micronuclei formation in cancer cell lines and induced ISGs in a cGAS- and STING-dependent manner.101,102,105–108 In mouse implanted tumor models, PARP inhibitors increased infiltration of CD8+ T cells to the tumor site. The gene discussed is PARP1; the disease is neoplasm.